triethylene glycol has been researched along with sansalvamide a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albericio, F; Fernández-Llamazares, AI; García, J; Pérez-Tomás, R; Soto-Cerrato, V; Spengler, J | 1 |
1 other study(ies) available for triethylene glycol and sansalvamide a
| Article | Year |
|---|---|
N-Triethylene glycol (N-TEG) as a surrogate for the N-methyl group: application to Sansalvamide A peptide analogs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Depsipeptides; Humans; Polyethylene Glycols | 2013 |